Fuda Xie

机构：Shenzhen Institute of Information Technology, City University of Hong Kong, Chinese University of Hong Kong, City University of Hong Kong, Shenzhen Research Institute, Prince of Wales Hospital, Chinese University of Hong Kong, Shenzhen, Cancer Research Center, University of Hong Kong · ORCID：0000-0001-9189-828X

发表论文 87 篇 · 总被引 1091 次 · h-index 13

代表论文

• YAP1 signaling and cancer: molecular pathways reveal novel targeting opportunities (2026 · Expert Opinion on Therapeutic Targets · 被引 2)
• Prevalence of MASLD and fibrosis assessed by transient elastography in U.S. adolescents: insights from NHANES 2017-2023 (2025 · Diabetology & Metabolic Syndrome · 被引 2)
• Development and validation of an explainable machine learning model using routine laboratory biomarkers for identifying prevalent MASLD: Evidence from two observational studies (2026 · Clinical and Experimental Medicine · 被引 1)
• MCM10, a novel YAP1/TEAD4 target, drives gastric cancer progression by bridging DNA replication to stemness acquisition (2026 · Molecular Cancer · 被引 1)
• HES1 inhibition overcomes CDK4/6 inhibitor resistance by targeting cancer stemness in lung adenocarcinoma (2026 · Journal of Experimental & Clinical Cancer Research)
• Trends in MASLD-related cirrhosis and liver cancer across diverse populations, 2010–2023 (2026 · Hepatology International)